• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从可生物降解的注射用凝胶制剂中控制释放避孕甾体:体外评价

Controlled release of a contraceptive steroid from biodegradable and injectable gel formulations: in vitro evaluation.

作者信息

Gao Z H, Shukla A J, Johnson J R, Crowley W R

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee, Memphis 38163, USA.

出版信息

Pharm Res. 1995 Jun;12(6):857-63. doi: 10.1023/a:1016209020160.

DOI:10.1023/a:1016209020160
PMID:7667190
Abstract

PURPOSE

The purpose of this study was to investigate the effects of formulation factors including varying wax concentration, drug loading and drug particle size, on drug release characteristics from both pure oil and gel formulations prepared with a combination of derivatized vegetable oil (Labrafil 1944 CS) and glyceryl palmitostearate (Precirol ATO 5), using levonorgestrel as a model drug.

METHODS

The effects of varying drug loadings, different drug particle sizes, and wax (Precirol) concentrations on in-vitro drug release rates were evaluated, and the mechanisms of drug release from the gels were determined.

RESULTS

Zero-order drug release rates from the 10% Precirol gel formulations containing 0.25, 0.50 and 2.00% w/v drug loadings were lower than those observed for oil formulations containing identical drug loadings. Higher zero-order release rates were observed from formulations containing smaller drug particles suspended in both oil and gel formulations. The mechanism of drug release from gels containing less than 0.25% w/w drug was diffusion-controlled. Increasing the wax concentrations in the gels from 5% w/w to 20% w/w significantly decreased the diffusivity of the drug through the gel formulations and markedly increased the force required to inject the gels from two different sizes of needles.

CONCLUSIONS

This study shows how modification of the physicochemical properties of the gel formulations by changing the drug particle size, wax concentration and drug loading, affects drug release characteristics from the system.

摘要

目的

本研究旨在考察包括蜡浓度变化、载药量和药物粒径等制剂因素对使用左炔诺孕酮作为模型药物,由衍生植物油(Labrafil 1944 CS)和甘油棕榈硬脂酸酯(Precirol ATO 5)组合制备的纯油制剂和凝胶制剂中药物释放特性的影响。

方法

评估了不同载药量、不同药物粒径和蜡(Precirol)浓度对体外药物释放速率的影响,并确定了凝胶中药物的释放机制。

结果

含0.25%、0.50%和2.00%(w/v)载药量的10% Precirol凝胶制剂的零级药物释放速率低于含相同载药量的油制剂。在油制剂和凝胶制剂中,含较小药物颗粒的制剂观察到更高的零级释放速率。含药量低于0.25%(w/w)凝胶的药物释放机制为扩散控制。将凝胶中的蜡浓度从5%(w/w)增加到20%(w/w)显著降低了药物在凝胶制剂中的扩散率,并显著增加了从两种不同尺寸针头注射凝胶所需的力。

结论

本研究表明,通过改变药物粒径、蜡浓度和载药量来改变凝胶制剂的物理化学性质,如何影响系统中的药物释放特性。

相似文献

1
Controlled release of a contraceptive steroid from biodegradable and injectable gel formulations: in vitro evaluation.从可生物降解的注射用凝胶制剂中控制释放避孕甾体:体外评价
Pharm Res. 1995 Jun;12(6):857-63. doi: 10.1023/a:1016209020160.
2
Controlled release of contraceptive steroids from biodegradable and injectable gel formulations: in vivo evaluation.生物可降解注射用凝胶制剂中甾体避孕药的控释:体内评价
Pharm Res. 1995 Jun;12(6):864-8. doi: 10.1023/a:1016261004230.
3
Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent-Meclizine HCl.用于难溶性止吐剂盐酸美克洛嗪缓释的脂质载挤出滚圆颗粒。
Lipids Health Dis. 2017 Apr 12;16(1):75. doi: 10.1186/s12944-017-0466-x.
4
In vitro release of hydrophobic drugs by oleogel rods with biocompatible gelators.水凝胶棒中疏水性药物的体外释放。
Eur J Pharm Sci. 2020 Sep 1;152:105413. doi: 10.1016/j.ejps.2020.105413. Epub 2020 Jun 12.
5
An oral controlled release system for ambroxol hydrochloride containing a wax and a water insoluble polymer.含蜡和不溶于水的聚合物的盐酸氨溴索口服控释系统。
Pharm Dev Technol. 2010 Jan-Feb;15(1):97-104. doi: 10.3109/10837450903013576.
6
Modification of drug release from acetaminophen granules by melt granulation technique - consideration of release kinetics.通过熔融制粒技术改变对乙酰氨基酚颗粒的药物释放 - 释放动力学的考量
Pak J Pharm Sci. 2006 Jan;19(1):22-7.
7
Development and evaluation of sustained-release ibuprofen-wax microspheres. II. In vitro dissolution studies.缓释布洛芬蜡质微球的研制与评价。II. 体外溶出度研究。
Pharm Res. 1994 Apr;11(4):575-9. doi: 10.1023/a:1018931002991.
8
In vitro release studies of piroxicam from oil-in-water creams and hydroalcoholic gel topical formulations.吡罗昔康从水包油乳膏剂和含醇水凝胶局部用制剂中的体外释放研究。
Drug Dev Ind Pharm. 2000 Apr;26(4):409-14. doi: 10.1081/ddc-100101247.
9
Influence of adsorbents in transdermal matrix patches on the release and the physical state of ethinyl estradiol and levonorgestrel.透皮基质贴片中吸附剂对炔雌醇和左炔诺孕酮释放和物理状态的影响。
Eur J Pharm Biopharm. 2011 Feb;77(2):240-8. doi: 10.1016/j.ejpb.2010.11.011. Epub 2010 Nov 30.
10
Influence of pH Modulation on Dynamic Behavior of Gel Layer and Release of Weakly Basic Drug from HPMC/Wax Matrices, Controlled by Acidic Modifiers Evaluated by Multivariate Data Analysis.pH调节对凝胶层动态行为及弱碱性药物从羟丙基甲基纤维素/蜡基质中释放的影响,由多元数据分析评估的酸性调节剂控制
AAPS PharmSciTech. 2017 May;18(4):1242-1253. doi: 10.1208/s12249-016-0588-x. Epub 2016 Jul 29.

引用本文的文献

1
Synergistic cytotoxicity of olive leaf extract-loaded lipid nanocarriers combined with Newcastle disease virus against cervical cancer cells.橄榄叶提取物负载的脂质纳米载体联合新城疫病毒对宫颈癌的协同细胞毒性作用。
PLoS One. 2024 Aug 14;19(8):e0308599. doi: 10.1371/journal.pone.0308599. eCollection 2024.
2
Biopolymeric nanoparticles.生物聚合物纳米颗粒
Sci Technol Adv Mater. 2010 Feb 26;11(1):014104. doi: 10.1088/1468-6996/11/1/014104. eCollection 2010 Feb.
3
Long-acting injectable hormonal dosage forms for contraception.长效注射用激素避孕剂型

本文引用的文献

1
Analysis of data on the medicament release from ointments.软膏剂药物释放数据的分析
J Pharm Sci. 1962 Aug;51:802-4. doi: 10.1002/jps.2600510825.
2
Influence of drug concentration on in vitro release of salicylic acid from ointment bases.
J Pharm Sci. 1974 Nov;63(11):1779-83. doi: 10.1002/jps.2600631127.
3
A method for the preparation of polylactic acid microcapsules of controlled particle size and drug loading.一种制备具有可控粒径和载药量的聚乳酸微胶囊的方法。
J Microencapsul. 1988 Apr-Jun;5(2):147-57. doi: 10.3109/02652048809056478.
Pharm Res. 2015 Jul;32(7):2180-91. doi: 10.1007/s11095-015-1686-2. Epub 2015 Apr 22.
4
Nanoparticles in relation to peptide and protein aggregation.与肽和蛋白质聚集相关的纳米颗粒
Int J Nanomedicine. 2014 Feb 12;9:899-912. doi: 10.2147/IJN.S54171. eCollection 2014.
5
A novel ropivacaine-loaded in situ forming implant prolongs the effect of local analgesia in rats.一种新型载罗哌卡因的原位形成植入物延长了局部镇痛在大鼠中的作用。
Arch Med Sci. 2013 Aug 30;9(4):614-21. doi: 10.5114/aoms.2012.30829. Epub 2012 Oct 8.
6
Effects of non-covalent self-association on the subcutaneous absorption of a therapeutic peptide.非共价自缔合对治疗性肽皮下吸收的影响。
Pharm Res. 1998 Feb;15(2):254-62. doi: 10.1023/a:1011918719017.
7
Controlled release of contraceptive steroids from biodegradable and injectable gel formulations: in vivo evaluation.生物可降解注射用凝胶制剂中甾体避孕药的控释:体内评价
Pharm Res. 1995 Jun;12(6):864-8. doi: 10.1023/a:1016261004230.
4
Microencapsulation and dissolution properties of a neuroleptic in a biodegradable polymer, poly(d,l-lactide).
J Pharm Sci. 1985 Jan;74(1):21-4. doi: 10.1002/jps.2600740106.
5
Sustained-release of urease from a poloxamer gel matrix.脲酶从泊洛沙姆凝胶基质中的缓释。
J Parenter Sci Technol. 1990 Mar-Apr;44(2):58-65.
6
Influence of average molecular weights of poly(DL-lactic acid-co-glycolic acid) copolymers 50/50 on phase separation and in vitro drug release from microspheres.聚(DL-乳酸-共-乙醇酸)50/50共聚物平均分子量对微球相分离及体外药物释放的影响
Pharm Res. 1990 Sep;7(9):928-34. doi: 10.1023/a:1015945806917.
7
Release rates of ketoprofen from poloxamer gels in a membraneless diffusion cell.
J Pharm Sci. 1991 Mar;80(3):280-3. doi: 10.1002/jps.2600800318.